Understanding the increasing incidence of neuroendocrine tumors

Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(5):377-385. doi: 10.1080/17446651.2023.2237593. Epub 2023 Jul 19.

Abstract

Introduction: Neuroendocrine tumors (NETs) are a diverse group of tumors with origins from different primary sites such as gastro-entero-pancreatic, lung and endocrine tissue. Worldwide, their incidence has increased in recent decades. Advances in imaging and better clinical awareness are traditionally attributed to this trend; however, other factors such as genetic and environmental contributors are appreciated as well.

Areas covered: The purpose of this article is to review the worldwide epidemiologic trends in incidence of NET through the decades and discuss the various factors potentially contributing to the observed changes in incidence trends.

Expert opinion: Overall, the incidence of NET has increased across the globe over the last few decades. Although multiple genetics and environmental factors have been proposed, the majority of this increase in incidence is secondary to earlier detection. Future studies will help in more accurate assessments and an improved understanding of disease incidence among patients with different grades and differentiation.

Keywords: Gastro-entero-pancreatic (GEP); NET genetic association; neuroendocrine tumor; pancreatic NET; worldwide NET trend.

Publication types

  • Review

MeSH terms

  • Humans
  • Incidence
  • Neuroendocrine Tumors* / epidemiology
  • Pancreatic Neoplasms* / epidemiology
  • Pancreatic Neoplasms* / pathology